Breaking news on conferences
Emerging Interventional Radiology Treatment With Drug-Eluting Stents Saves Limbs published
Tue, 16 Mar 2010 01:00:00 PDT
In the United States, more than 100,000 amputations are performed each year on individuals with critical limb ischemia, the most severe form of peripheral arterial disease (PAD). The number one priority in treating these patients is to re-establish blood flow to avoid limb amputation...
Imaging Diagnostic Systems Exhibits At The 2010 European College Of Radiology Conference published
Sun, 14 Mar 2010 00:00:00 PDT
Imaging Diagnostic Systems, Inc., (OTCBB:IMDS), a pioneer in laser optical breast imaging; exhibited its CT Laser Mammography (CTLM®) system at the European College of Radiology, March 4-8, 2010, in Vienna, Austria. ECR 2010 had over 19,000 international delegates, an increase of attendance over the previous years...
Are Cities Designed For Women? Penn-ICOWHI Conference Examines Urban Women's Health published
Sat, 13 Mar 2010 02:00:00 PDT
Women comprise more than half the population of the nation's cities, are three times as likely as their male counterparts to live alone after the age of 65, and are primary caregivers for their families at all ages and stages of life...
Diary Note: East Of England Muscle Disease Conference published
Thu, 11 Mar 2010 07:00:00 PDT
What Families living with muscle disease in the East of England are joining forces with clinicians and MPs at an inaugural conference for the region, organised by the Muscular Dystrophy Campaign. The conference will be an opportunity for families to learn more about fighting for better muscle disease services in their region and to find out how local campaigning can make a real difference...
Seaweed Extract May Hold Promise For Non-Hodgkin's Lymphoma Treatment published
Thu, 11 Mar 2010 03:00:00 PDT
Seaweed extract may eventually emerge as a lymphoma treatment, according to laboratory research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held here March 7-10, 2010...
2010 Max Planck Research Award For NYU Dental Professor Dr. Timothy Bromage published
Thu, 11 Mar 2010 00:00:00 PDT
New York University College of Dentistry's Dr. Timothy Bromage has been selected to receive the 2010 Max Planck Research Award. Dr. Bromage will collaborate with Dr...
Differing Patient And Doctor Expectations From Joint Replacement Surgeries published
Thu, 11 Mar 2010 00:00:00 PDT
While physicians strive to set realistic expectations for patients undergoing knee and hip joint replacements, a new study reveals that doctor and patient expectations are sometimes not aligned...
Osteoporosis Drug Improves Healing After Rotator Cuff Surgery published
Thu, 11 Mar 2010 00:00:00 PDT
Tears in the shoulder's rotator cuff, a common sports injury, are painful and restricting. Surgery to repair the damage is successful for pain management, but in many patients it does not result in full recovery of function due to poor healing. New research shows an approved therapy for osteoporosis, Forteo, may speed healing and improve patient outcomes...
Dr Avijit Banerjee Confirmed For 2010 British Dental Conference And Exhibition published
Tue, 09 Mar 2010 11:00:00 PDT
The BDA is proud to announce that the respected clinical expert Dr Avijit Banerjee has been confirmed to join the prestigious panel of speakers appearing at the 2010 British Dental Conference and Exhibition, to be held on the 20 - 22 May 2010 at the Liverpool Arena and Convention Centre (ACC)...
British Dental Conference And Exhibition 2010 published
Tue, 09 Mar 2010 10:00:00 PDT
Tickets are now available for the BDA's British Dental Conference and Exhibition, which takes place at Liverpool's Arena and Convention Centre (ACC) from 20-22 May 2010. The conference features a wide selection of both clinical and motivational speakers who are guaranteed to inspire delegates with new ideas...
ESMO Conference On Sarcoma And GIST: Spotlight On Rare Tumors In Hunt For New Cancer Treatments published
Tue, 09 Mar 2010 04:00:00 PDT
New breakthrough treatments for the most common cancers could soon come from cutting-edge research into some of the world's rarest tumors...
Accumetrics To Host Industry-Expert Theater Presentation At 59th Annual American College Of Cardiology 2010 Scientific Sessions published
Tue, 09 Mar 2010 01:00:00 PDT
Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow® System, the first rapid and easy-to-use diagnostic system for measuring platelet reactivity to multiple antiplatelet agents (e.g. Plavix® and aspirin), announced that the company will host an industry expert theater presentation on Monday, March 15, during the 59th annual American College of Cardiology Meeting...
NxStage Announces New FREEDOM Data Showing The Positive Impact Of Its Daily Home Hemodialysis Therapy On Sleep Quality And Restless Legs Syndrome published
Tue, 09 Mar 2010 01:00:00 PDT
Booths # 23-25 at the Annual Dialysis Conference -- NxStage Medical, Inc...
PROGENSA(R) PCA3 Assay Can Help Guide Repeat Prostate Biopsy Decisions, Data Presented At Leading Medical Meeting Confirm published
Tue, 09 Mar 2010 01:00:00 PDT
Gen-Probe's (Nasdaq: GPRO) PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco...
Acologix Presents Data On Cartilage Regeneration By AC-100 At The 56th Annual Meeting Of The Orthopaedic Research Society published
Tue, 09 Mar 2010 01:00:00 PDT
Acologix, Inc., a privately held biopharmaceutical company, announced the results of its latest preclinical study demonstrating that AC-100, its therapeutic product candidate derived from an endogenous human protein, promotes cartilage regeneration in a large animal model. The data will be presented by Dr. David M...
The Active Handrest: High-Tech Handrest For Precise Tasks By Surgeons, Machinists, Artists published
Mon, 08 Mar 2010 04:00:00 PDT
University of Utah engineers developed a computer-controlled, motorized hand and arm support that will let doctors, artists and others precisely control scalpels, brushes and tools over a wider area than otherwise possible, and with less fatigue...
University Of Chicago And Ataxia Foundation Team Up For Annual Scientific And Patient Meetings published
Mon, 08 Mar 2010 03:00:00 PDT
The National Ataxia Foundation (NAF), in conjunction with the University of Chicago program in pathobiology and translational neuroscience, will hold its third annual Ataxia Investigators Meeting March 9-11, 2010, at the Hyatt Regency O'Hare, in Rosemont, Ill. A three-day meeting for patients, caregivers and families will follow at the same location...
Many Voices Needed To Collaborate On Efforts To Build A More Sustainable Future published
Mon, 08 Mar 2010 03:00:00 PDT
Leading futurists and technologists have worked with the National Academy of Engineering (NAE) to identify "Grand Challenges for Engineering in the 21st Century," focusing on technological breakthroughs needed to build sustainable societies and improve the quality of life in a growing and increasingly complex world. To help launch a call to action toward achieving these goals, the Ira A...
What Do The Social Sciences Do For Me? published
Sat, 06 Mar 2010 01:00:00 PDT
Your average conversation down the pub on a Friday night could include topics such as 'the kids are driving me mad this week' or 'the litter in our street is out of control' and 'have you seen that change 4 life advert on TV?' - but the crucial research behind the topics rarely gets the same attention...
Poniard Pharmaceuticals Presents Positive Survival Data From A Phase 2 Clinical Study Of Picoplatin In Metastatic Prostate Cancer published
Sat, 06 Mar 2010 01:00:00 PDT
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC)...
Phase III REGION-I Study Shows PEP005 (ingenol Mebutate) Gel 0.05% May Reduce Pre-Cancerous Skin Lesions In Patients With Actinic Keratosis published
Sat, 06 Mar 2010 01:00:00 PDT
Specialty pharmaceutical company LEO Pharma announced that findings from a Phase III study evaluating PEP005 (ingenol mebutate) Gel 0.05% to treat actinic keratosis (AK), a common pre-cursor to skin cancer, were presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) (Scientific Session Poster Discussion: P105)...
A Rocking Good Lecture published
Sat, 06 Mar 2010 00:00:00 PDT
A University academic who left school early with dreams of being a rock star has been recognised for his internationally outstanding work in microbiology and his studies into the social lifestyle of the opportunistic bacterium Pseudomonas aeruginosa - the leading cause of death in Cystic Fibrosis patients and an important cause of hospital acquired infections...
Current Opinion Conference On Cellular Host-Pathogen Interactions Announced By Elsevier published
Sat, 06 Mar 2010 00:00:00 PDT
Elsevier, the world-leading publisher of scientific, technical and medical information products and services has announced that the prestigious journal Current Opinion in Cell Biology (http://www.elsevier.com/locate/ceb) will host a Cellular Host-Pathogen Interactions Conference, in Amsterdam, The Netherlands, on 5-7 September 2010 (http://conferences.current-opinion.com)...
2nd European Lung Cancer Conference published
Fri, 05 Mar 2010 06:00:00 PDT
Rapid advances in drug development, genetics and multidisciplinary treatment have brought the field of oncology to a critical moment, says Dr. Rafael Rosell from the Catalan Institute of Oncology in Badalona, Spain, co-chair of the second European Lung Cancer Conference (ELCC), which will be held in Geneva, Switzerland from 28 April to 1 May 2010...
Continuing Spirituality Research: Conference published
Fri, 05 Mar 2010 06:00:00 PDT
The 2nd Conference on the Study of Contemporary Spirituality will take place at the University of Haifa on Monday, 8 March, 2010. The conference will host an astounding 32 sessions and dozens of lectures presenting studies that encompass the field of contemporary spiritualism in Israel and around the world. "This is a wide phenomenon that touches many audiences and comprises a variety of areas...
)
|
|
